PPMD's Blog – November 2012 Archive (1)

Summit: Repeat dosing of SMT C1100 for treatment of Duchenne meets endpoints in Phase 1 trial

News Release:

Summit Corporation plc 

(‘Summit’ or ‘the Company’)



REPEAT DOSING OF SMT C1100 FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY MEETS ENDPOINTS IN PHASE 1 CLINICAL TRIAL 

 

New formulation delivers drug levels that are predicted to significantly increase utrophin…

Continue

Added by PPMD on November 7, 2012 at 10:00am — No Comments

Monthly Archives

2018

2017

2016

2015

2014

2013

2012

2011

2010

Need help using this community site? Visit Ning's Help Page.

Members

Events

© 2019   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service